Opaleye Management Inc. 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-26 11:00 am Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Opaleye Management Inc. | 0 0.000% | -1,487,800 (Position Closed) | Filing |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Opaleye Management Inc. | 1,487,800 5.220% | 61,800 (+4.33%) | Filing |
| 2020-08-21 5:15 pm Purchase | 2020-08-11 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Opaleye Management Inc. | 1,426,000 5.040% | 1,426,000 (New Position) | Filing |